Crohn Disease Clinical Trials in Clermont-Ferrand

10 recruitingClermont-Ferrand, France

Showing 110 of 10 trials

Recruiting
Phase 2Phase 3

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease
Janssen Research & Development, LLC1,092 enrolled324 locationsNCT07196722
Recruiting

Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)

Crohn Disease (CD)Transmural Response
University Hospital, Clermont-Ferrand100 enrolled4 locationsNCT07308067
Recruiting
Not Applicable

Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin

Crohn Disease (CD)Ileocolic ResectionPost-endoscopic Operative Reccurence
University Hospital, Clermont-Ferrand42 enrolled8 locationsNCT06972901
Recruiting
Not Applicable

Evaluation of Sleep Changes in Inflammatory Bowel Diseases (IBD) Patients.

Crohn DiseaseUlcerative ColitisDisease Bowel
Hospices Civils de Lyon216 enrolled4 locationsNCT05835973
Recruiting
Phase 2

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohn Disease
Abivax S.A.212 enrolled149 locationsNCT06456593
Recruiting
Phase 2

Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

Crohn Disease (CD)
Madeleine Bezault80 enrolled12 locationsNCT06925061
Recruiting
Not Applicable

The CROCO Study: CROhn's Disease COhort Study

Crohn Disease
GLSMED Learning Health S.A.600 enrolled20 locationsNCT05420233
Recruiting

TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1)

Crohn Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives210 enrolled18 locationsNCT05903066
Recruiting
Not Applicable

Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group

Crohn Disease
Saint-Louis Hospital, Paris, France575 enrolled17 locationsNCT03458195
Recruiting
Not Applicable

STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

MRICrohn DiseaseCalprotectin
University Hospital, Clermont-Ferrand180 enrolled17 locationsNCT04973423